Maayan Karlinski Zur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maayan Karlinski Zur has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Orly Reiner
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
2 shared publications - Rita Schmidt
Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel
2 shared publications Tamar Sapir
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
2 shared publications- Alon Savidor
The De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel
1 shared publication - Amir Prior
The De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel
1 shared publication - Amnon Buxboim
The Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication
Latest Publications
- Open Access
Intelliwaste: NMR of 13 C-labeled Spent Media Enables Non-Invasive Metabolic Fingerprinting of Pluripotent Stem Cells and LIS1-Associated Neuropathology
Metabolic dysregulation is increasingly recognized as a key contributor to neurodevelopmental disorders. Here, we present Intelliwaste , a non-invasive, cost-effective method for profiling carbon metabolism in pluripotent stem cells and brain organoids using 13 C-labeled metabolites and 1 H and 13 C NMR spectroscopy. This approach enables longitudinal analysis of extracellular fluxes without disrupting cell viability. We apply Intelliwaste to human embryonic stem cells (hESCs) cultured in a defined media enriched with >95% 13 C 1 -Glucose. Under these conditions, 13 C 3 -lactate emerged as the most abundant labeled product, with 20–50-fold lower fluxes to 13 C 3 -alanine, 13 C 2 -acetate, 13 C 3 -serine, and 13 C 3 -pyruvate, and 100–300-fold lower fluxes to 13 C 1 -formate and multiple 13 C-labeled glutamate species. These profiles allow for precise quantification of fractional metabolic isotopic labeling and glucose-derived carbon flow. To demonstrate biological utility, we first examine the effect of L-glutamine omission , which selectively reduces 13 C 3 -alanine/ 13 C 3 -lactate and 13 C 4 -glutamate/ 13 C 3 -lactate flux ratios, while the 13 C 3 -Glutamate/ 13 C 3 -Lactate and 13 C 2 -Glutamate/ 13 C 3 -Lactate flux ratios remained unchanged. These findings suggest a specific role for extracellular glutamine in modulating the activity of alanine aminotransferase and pyruvate carboxylase. We then characterized LIS1 mutant hESCs —a model of lissencephaly—and observed significantly increased flux ratios involving 13 C 4 -, 13 C 3 -, and 13 C 2 -glutamate relative to 13 C 3 -lactate, indicating enhanced glutamate production via the TCA cycle. These findings establish Intelliwaste as a powerful tool for metabolic profiling in the study of human neurodevelopment and disease. Its non-destructive nature makes it particularly well-suited for tracking metabolic changes during differentiation and in patient-derived organoid models of neurological disorders.
Open AccessIntelliwaste: NMR of 13 C-labeled Spent Media Enables Non-Invasive Metabolic Fingerprinting of Pluripotent Stem Cells and LIS1-Associated Neuropathology
Metabolic dysregulation is increasingly recognized as a key contributor to neurodevelopmental disorders. Here, we present Intelliwaste , a non-invasive, cost-effective method for profiling carbon metabolism in pluripotent stem cells and brain organoids using 13 C-labeled metabolites and 1 H and 13 C NMR spectroscopy. This approach enables longitudinal analysis of extracellular fluxes without disrupting cell viability. We apply Intelliwaste to human embryonic stem cells (hESCs) cultured in a defined media enriched with >95% 13 C 1 -Glucose. Under these conditions, 13 C 3 -lactate emerged as the most abundant labeled product, with 20–50-fold lower fluxes to 13 C 3 -alanine, 13 C 2 -acetate, 13 C 3 -serine, and 13 C 3 -pyruvate, and 100–300-fold lower fluxes to 13 C 1 -formate and multiple 13 C-labeled glutamate species. These profiles allow for precise quantification of fractional metabolic isotopic labeling and glucose-derived carbon flow. To demonstrate biological utility, we first examine the effect of L-glutamine omission , which selectively reduces 13 C 3 -alanine/ 13 C 3 -lactate and 13 C 4 -glutamate/ 13 C 3 -lactate flux ratios, while the 13 C 3 -Glutamate/ 13 C 3 -Lactate and 13 C 2 -Glutamate/ 13 C 3 -Lactate flux ratios remained unchanged. These findings suggest a specific role for extracellular glutamine in modulating the activity of alanine aminotransferase and pyruvate carboxylase. We then characterized LIS1 mutant hESCs —a model of lissencephaly—and observed significantly increased flux ratios involving 13 C 4 -, 13 C 3 -, and 13 C 2 -glutamate relative to 13 C 3 -lactate, indicating enhanced glutamate production via the TCA cycle. These findings establish Intelliwaste as a powerful tool for metabolic profiling in the study of human neurodevelopment and disease. Its non-destructive nature makes it particularly well-suited for tracking metabolic changes during differentiation and in patient-derived organoid models of neurological disorders.
- Open Access
- 1 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Altered extracellular matrix structure and elevated stiffness in a brain organoid model for disease
The viscoelastic properties of tissues influence their morphology and cellular behavior, yet little is known about changes in these properties during brain malformations. Lissencephaly, a severe cortical malformation caused by LIS1 mutations, results in a smooth cortex. Here, we show that human-derived brain organoids with LIS1 mutation exhibit increased stiffness compared to controls at multiple developmental stages. This stiffening correlates with abnormal extracellular matrix (ECM) expression and organization, as well as elevated water content, measured by diffusion-weighted MRI. Short-term MMP9 treatment reduces both stiffness and water diffusion levels to control values. Additionally, a computational microstructure mechanical model predicts mechanical changes based on ECM organization. These findings suggest that LIS1 plays a critical role in ECM regulation during brain development and that its mutation leads to significant viscoelastic alterations.
- 1 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessAltered extracellular matrix structure and elevated stiffness in a brain organoid model for disease
The viscoelastic properties of tissues influence their morphology and cellular behavior, yet little is known about changes in these properties during brain malformations. Lissencephaly, a severe cortical malformation caused by LIS1 mutations, results in a smooth cortex. Here, we show that human-derived brain organoids with LIS1 mutation exhibit increased stiffness compared to controls at multiple developmental stages. This stiffening correlates with abnormal extracellular matrix (ECM) expression and organization, as well as elevated water content, measured by diffusion-weighted MRI. Short-term MMP9 treatment reduces both stiffness and water diffusion levels to control values. Additionally, a computational microstructure mechanical model predicts mechanical changes based on ECM organization. These findings suggest that LIS1 plays a critical role in ECM regulation during brain development and that its mutation leads to significant viscoelastic alterations.